indie Semi Director Maintains Strong Position Despite $40K Stock Sale

Rhea-AI Filing Summary

indie Semiconductor director Sonalee Elizabeth Parekh has executed a planned sale of 11,841 shares of Class A Common Stock at a weighted average price of $3.42 per share on June 16, 2025, leaving her with a direct ownership of 119,857 shares.

The transaction was conducted pursuant to a Rule 10b5-1 trading plan established on September 13, 2024. The sales were executed through multiple transactions with prices ranging from $3.26 to $3.54 per share. The trading plan includes automated open market sales scheduled through June 30, 2025.

Key details:

• Transaction type: Sale of non-derivative securities
• Trading plan compliance: Executed under pre-established Rule 10b5-1 plan
• Form of ownership: Direct
• Reporting person role: Director

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parekh Sonalee Elizabeth

(Last) (First) (Middle)

C/O INDIE SEMICONDUCTOR

32 JOURNEY

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
indie Semiconductor, Inc. [ INDI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/16/2025		S(1)		11,841	D	$3.42(2)	119,857	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales made in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024. The Reporting Person's Rule 10b5-1 plan includes automated open market sales of the Issuer's Class A common stock through June 30, 2025.

2. The price reported in Column 4 is a weighted average price. The shares reported in this Form 4 were sold in separate transactions at prices ranging from $3.26 to $3.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range set forth in this footnote.

Remarks:

	/s/ Sonalee Parekh, by Naixi Wu pursuant to power of attorney filed on June 21, 2021	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of INDI stock did Director Sonalee Parekh sell on June 16, 2025?

Director Sonalee Parekh sold 11,841 shares of INDI Class A Common Stock on June 16, 2025.

What was the selling price of INDI shares in Director Parekh's June 2025 transaction?

The shares were sold at a weighted average price of $3.42, with individual transactions ranging from $3.26 to $3.54 per share.

How many INDI shares does Sonalee Parekh own after the June 2025 sale?

Following the reported transaction, Sonalee Parekh directly owns 119,857 shares of INDI Class A Common Stock.

Was INDI Director Parekh's stock sale part of a pre-planned trading arrangement?

Yes, the sales were made pursuant to a Rule 10b5-1 trading plan adopted by Parekh on September 13, 2024. The plan includes automated open market sales through June 30, 2025.